SecSonar.com

Gevo, Inc. (GEVO)

Gevo, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Gevo, Inc. (GEVO) is a Chemicals - Specialty company based in US with a market capitalization of $457.6M. Revenue grew 849.3% year-over-year and free cash flow was negative at -$43.5M. This page tracks GEVO's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 122 employees · IPO Feb 9, 2011

Valuation

Valuation & price

$1.68 · as of May 17, 2026 · -39.6% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

0.98

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$2.73$1.95$1.17Jul 25Dec 25Jul 26Jul 7, 25$1.44Jul 9, 25$1.60Jul 11, 25$1.49Jul 15, 25$1.45Jul 17, 25$1.51Jul 21, 25$1.48Jul 23, 25$1.55Jul 25, 25$1.47Jul 29, 25$1.38Jul 31, 25$1.30Aug 4, 25$1.23Aug 6, 25$1.17Aug 11, 25$1.25Aug 13, 25$1.98Aug 15, 25$1.80Aug 19, 25$1.59Aug 21, 25$1.61Aug 25, 25$1.78Aug 27, 25$1.78Aug 29, 25$1.73Sep 3, 25$1.63Sep 5, 25$1.67Sep 9, 25$1.61Sep 11, 25$1.66Sep 16, 25$1.89Sep 18, 25$2.09Sep 22, 25$1.98Sep 24, 25$2.09Sep 26, 25$2.06Sep 30, 25$1.96Oct 2, 25$2.03Oct 6, 25$2.22Oct 8, 25$2.29Oct 10, 25$2.19Oct 14, 25$2.56Oct 16, 25$2.64Oct 21, 25$2.44Oct 23, 25$2.41Oct 27, 25$2.39Oct 29, 25$2.29Oct 31, 25$2.34Nov 4, 25$2.11Nov 6, 25$2.05Nov 10, 25$2.12Nov 12, 25$2.12Nov 14, 25$1.97Nov 18, 25$1.95Nov 20, 25$1.87Nov 25, 25$2.08Nov 28, 25$2.14Dec 2, 25$2.16Dec 4, 25$2.37Dec 8, 25$2.23Dec 10, 25$2.25Dec 12, 25$2.32Dec 16, 25$2.14Dec 18, 25$2.17Dec 22, 25$2.18Dec 24, 25$2.16Dec 29, 25$1.95Jan 2, 26$2.06Jan 6, 26$2.01Jan 8, 26$1.99Jan 12, 26$2.04Jan 14, 26$2.06Jan 16, 26$2.01Jan 21, 26$2.01Jan 23, 26$2.19Jan 27, 26$2.08Jan 29, 26$2.04Feb 2, 26$1.91Feb 4, 26$1.84Feb 9, 26$1.90Feb 11, 26$1.87Feb 13, 26$1.86Feb 18, 26$1.89Feb 20, 26$1.86Feb 24, 26$1.83Feb 26, 26$1.86Mar 2, 26$1.90Mar 4, 26$1.91Mar 6, 26$2.14Mar 10, 26$2.30Mar 12, 26$2.43Mar 17, 26$2.35Mar 19, 26$2.34Mar 23, 26$2.35Mar 25, 26$2.46Mar 27, 26$2.52Mar 31, 26$2.73Apr 2, 26$2.30Apr 7, 26$1.97Apr 9, 26$1.91Apr 13, 26$2.03Apr 15, 26$2.00Apr 17, 26$1.70Apr 22, 26$1.85Apr 24, 26$1.80Apr 28, 26$1.83Apr 30, 26$1.91May 4, 26$2.07May 6, 26$2.05May 8, 26$1.83May 12, 26$1.71May 14, 26$1.68May 18, 26$1.74May 20, 26$1.64May 22, 26$1.77May 28, 26$1.90Jun 1, 26$1.84Jun 3, 26$1.75Jun 5, 26$1.63Jun 9, 26$1.50Jun 11, 26$1.47Jun 15, 26$1.43Jun 17, 26$1.49Jun 22, 26$1.42Jun 24, 26$1.43Jun 26, 26$1.40Jul 2, 26$1.41
$1.1552-week range$2.78
Loading valuation history…

Fundamentals

Key fundamentals

$457.6M

Market cap

849.3%

Revenue growth (YoY)

30.2%

Gross margin

-$43.5M

Free cash flow (USD)

$166.4M

Net debt

1.0%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Basic Materials

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$26.5MFY 2017$27.3MFY 2018$32.9MFY 2019$24.5MFY 2020$5.5MFY 2021$533.0KFY 2022$1.2MFY 2023$17.2MFY 2024$16.9MFY 2025$160.6M
$26.5M$160.6M

Free cash flow by year

2016 → 2025

FY 2016$-26.5MFY 2017$-22.5MFY 2018$-18.1MFY 2019$-26.8MFY 2020$-25.2MFY 2021$-114.2MFY 2022$-128.4MFY 2023$-108.2MFY 2024$-108.5MFY 2025$-43.5M
-$26.5M-$43.5M

Gross margin by year

2021 → 2025

FY 2021-1342.2%FY 2022-640.3%FY 202330.3%FY 202429.1%FY 202530.2%
-1342.2%30.2%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

14

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 7, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider sellInsider Sell $50K · 10b5-1 PlanBloom Paul D · Director, CEO · $50.2KJun 15, 2026Filing
  • Insider sellInsider Sell $50K · 10b5-1 PlanRyan Christopher Michael · President & COO · $50.2KJun 15, 2026Filing
  • Insider sellInsider Sell $13K · 10b5-1 PlanShafer Andrew · Chief Mktg Cust & Brnd Officer · $13.5KJun 15, 2026Filing
  • Insider sellInsider Sell $6K · 10b5-1 PlanGendenjamts Davaajargal · VP Acctg and Treasurer · $6.1KJun 15, 2026Filing
  • Insider sellInsider Sell $22K · 10b5-1 PlanBowron Kimberly T · Chief of Staff · $22KJun 15, 2026Filing
  • Insider sellInsider Sell $88K · 10b5-1 PlanAgiri Oluwagbemileke Yusuf · CFO · $88.1KJun 15, 2026Filing
  • Insider sellInsider Sell $221K · 10b5-1 PlanGruber Patrick R. · Director · $220.9KJun 15, 2026Filing
  • Insider sellInsider Sell $133K · 10b5-1 PlanBloom Paul D · Director, CEO · $133.3KMay 29, 2026Filing
  • Insider sellInsider Sell $154K · 10b5-1 PlanRyan Christopher Michael · President & COO · $154.3KMay 29, 2026Filing
  • Insider sellInsider Sell $57K · 10b5-1 PlanAgiri Oluwagbemileke Yusuf · CFO · $56.7KMay 29, 2026Filing

Questions

Frequently asked questions

What is Gevo, Inc.'s market cap?

Gevo, Inc. (GEVO) has a market capitalization of $457.6M.

What is GEVO's P/E ratio?

A meaningful P/E ratio is not available for GEVO — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is GEVO's price-to-book (P/B) ratio?

GEVO trades at 0.98 times book value per share.

Are insiders buying GEVO stock?

SEC Form 4 filings show no open-market insider buys at Gevo, Inc. in the last 90 days (14 sells).

Same arena

Related companies in Chemicals - Specialty

OEC

Orion Engineered Carbons S.A.

$436.4M

ALTO

Alto Ingredients, Inc.

$422.7M

HDSN

Hudson Technologies, Inc.

$226.5M

CMT

Core Molding Technologies, Inc.

$221.8M

KOP

Koppers Holdings Inc.

$790M

FSI

Flexible Solutions International, Inc.

$83.9M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.